RASAL2 activates RAC1 to promote triple-negative breast cancer progression.
Feng M, Bao Y, Li Z, Li J, Gong M, Lam S, Wang J, Marzese DM, Donovan N, Tan EY, Hoon DS, Yu Q.
Feng M, et al. Among authors: li z, li j.
J Clin Invest. 2014 Dec;124(12):5291-304. doi: 10.1172/JCI76711. Epub 2014 Nov 10.
J Clin Invest. 2014.
PMID: 25384218
Free PMC article.
Clinical Trial.